Exact Mass: 537.181
Exact Mass Matches: 537.181
Found 395 metabolites which its exact mass value is equals to given mass value 537.181
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3-Demethylsimmondsin 2'-(Z)-ferulate
3-Demethylsimmondsin 2-(Z)-ferulate is found in coffee and coffee products. 3-Demethylsimmondsin 2-(Z)-ferulate is a constituent of jojoba meal Constituent of jojoba meal. 3-Demethylsimmondsin 2-(Z)-ferulate is found in coffee and coffee products, fats and oils, and nuts.
4-Demethylsimmondsin 2'-(E)-ferulate
4-Demethylsimmondsin 2-(E)-ferulate is found in coffee and coffee products. 4-Demethylsimmondsin 2-(E)-ferulate is a constituent of jojoba meal Constituent of jojoba meal. 4-Demethylsimmondsin 2-(E)-ferulate is found in coffee and coffee products, fats and oils, and nuts.
N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-phenylbenzamide
Desmethyl Bosentan
N-(2,12-dimethoxy-3,11,16-trimethyl-1,4,10,13-tetraoxo-1,5,6,7,9,10,13,14,14a,15-decahydro-4H-6,15-epiazano-benzo[4,5]azocino[1,2-b]isoquinolin-9-ylmethyl)-2-oxo-propionamide|Saframycin B
4-(2-hydroxyethyl)phenyl 5-O-nicotinyl-beta-D-apiofuranosyl(1->2)-beta-D-glucopyranoside|cucurbitoside H
(2S,3S,4R,4aS,6S,11bS)-1,2,3,4,5,6-hexahydro-3,4-dimethoxy-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl-(2Z)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate|(6beta,7beta,8beta,10beta)-8,10-epoxy-7,8-dimethoxy-2,3-(methylenedioxy)hasubanan-6-yl-(Z)-3-hydroxy-4-methoxycinnamate|hernsubanine A
6,7-di-O-methyl-N-deacetylisoipecosidic acid|6,7-di-O-methyl-N-deacetylisopecosidic acid
KT5720
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
Ala Asp Phe Trp
Ala Asp Trp Phe
Ala Phe Asp Trp
Ala Phe Trp Asp
Ala Met Met Trp
Ala Met Trp Met
Ala Trp Asp Phe
Ala Trp Phe Asp
Ala Trp Met Met
Cys Asp Asp Trp
Cys Asp Trp Asp
Cys Glu Met Arg
Cys Glu Arg Met
Cys Glu Thr Trp
Cys Glu Trp Thr
Cys Met Glu Arg
Cys Met Arg Glu
Cys Met Val Trp
Cys Met Trp Val
Cys Arg Glu Met
Cys Arg Met Glu
Cys Thr Glu Trp
Cys Thr Trp Glu
Cys Val Met Trp
Cys Val Trp Met
Cys Trp Asp Asp
Cys Trp Glu Thr
Cys Trp Met Val
Cys Trp Thr Glu
Cys Trp Val Met
Asp Ala Phe Trp
Asp Ala Trp Phe
Asp Cys Asp Trp
Asp Cys Trp Asp
Asp Asp Cys Trp
Asp Asp Trp Cys
Asp Glu Phe Gln
Asp Glu Gln Phe
Asp Phe Ala Trp
Asp Phe Glu Gln
Asp Phe Gln Glu
Asp Phe Trp Ala
Asp Met Ser Trp
Asp Met Trp Ser
Asp Gln Glu Phe
Asp Gln Phe Glu
Asp Ser Met Trp
Asp Ser Trp Met
Asp Trp Ala Phe
Asp Trp Cys Asp
Asp Trp Asp Cys
Asp Trp Phe Ala
Asp Trp Met Ser
Asp Trp Ser Met
Glu Cys Met Arg
Glu Cys Arg Met
Glu Cys Thr Trp
Glu Cys Trp Thr
Glu Asp Phe Gln
Glu Asp Gln Phe
Glu Glu Phe Asn
Glu Glu Asn Phe
Glu Phe Asp Gln
Glu Phe Glu Asn
Glu Phe Gly Trp
Glu Phe Asn Glu
Glu Phe Gln Asp
Glu Phe Trp Gly
Glu Gly Phe Trp
Glu Gly Trp Phe
Glu Lys Met Met
Glu Met Cys Arg
Glu Met Lys Met
Glu Met Met Lys
Glu Met Met Gln
Glu Met Gln Met
Glu Met Arg Cys
Glu Asn Glu Phe
Glu Asn Phe Glu
Glu Gln Asp Phe
Glu Gln Phe Asp
Glu Gln Met Met
Glu Arg Cys Met
Glu Arg Met Cys
Glu Thr Cys Trp
Glu Thr Trp Cys
Glu Trp Cys Thr
Glu Trp Phe Gly
Glu Trp Gly Phe
Glu Trp Thr Cys
Phe Ala Asp Trp
Phe Ala Trp Asp
Phe Asp Ala Trp
Phe Asp Glu Gln
Phe Asp Gln Glu
Phe Asp Trp Ala
Phe Glu Asp Gln
Phe Glu Glu Asn
Phe Glu Gly Trp
Phe Glu Asn Glu
Phe Glu Gln Asp
Phe Glu Trp Gly
Phe Gly Glu Trp
Phe Gly Trp Glu
Phe Asn Glu Glu
Phe Gln Asp Glu
Phe Gln Glu Asp
Phe Trp Ala Asp
Phe Trp Asp Ala
Phe Trp Glu Gly
Phe Trp Gly Glu
Gly Glu Phe Trp
Gly Glu Trp Phe
Gly Phe Glu Trp
Gly Phe Trp Glu
Gly Trp Glu Phe
Gly Trp Phe Glu
His His Met Asn
His His Asn Met
His Met His Asn
His Met Asn His
His Asn His Met
His Asn Met His
Lys Glu Met Met
Lys Met Glu Met
Lys Met Met Glu
Met Ala Met Trp
Met Ala Trp Met
Met Cys Glu Arg
Met Cys Arg Glu
Met Cys Val Trp
Met Cys Trp Val
Met Asp Ser Trp
Met Asp Trp Ser
Met Glu Cys Arg
Met Glu Lys Met
Met Glu Met Lys
Met Glu Met Gln
Met Glu Gln Met
Met Glu Arg Cys
Met His His Asn
Met His Asn His
Met Lys Glu Met
Met Lys Met Glu
Met Met Ala Trp
Met Met Glu Lys
Met Met Glu Gln
Met Met Lys Glu
Met Met Gln Glu
Met Met Trp Ala
Met Asn His His
Met Pro Gln Tyr
Met Pro Tyr Gln
Met Gln Glu Met
Met Gln Met Glu
Met Gln Pro Tyr
Met Gln Tyr Pro
Met Arg Cys Glu
Met Arg Glu Cys
Met Ser Asp Trp
Met Ser Trp Asp
Met Thr Thr Trp
Met Thr Trp Thr
Met Val Cys Trp
Met Val Trp Cys
Met Trp Ala Met
Met Trp Cys Val
Met Trp Asp Ser
Met Trp Met Ala
Met Trp Ser Asp
Met Trp Thr Thr
Met Trp Val Cys
Met Tyr Pro Gln
Met Tyr Gln Pro
Asn Glu Glu Phe
Asn Glu Phe Glu
Asn Phe Glu Glu
Asn His His Met
Asn His Met His
Asn Met His His
Asn Asn Gln Tyr
Asn Asn Tyr Gln
Asn Gln Asn Tyr
Asn Gln Tyr Asn
Asn Tyr Asn Gln
Asn Tyr Gln Asn
Pro Met Gln Tyr
Pro Met Tyr Gln
Pro Gln Met Tyr
Pro Gln Tyr Met
Pro Tyr Met Gln
Pro Tyr Gln Met
Gln Asp Glu Phe
Gln Asp Phe Glu
Gln Glu Asp Phe
Gln Glu Phe Asp
Gln Glu Met Met
Gln Phe Asp Glu
Gln Phe Glu Asp
Gln Met Glu Met
Gln Met Met Glu
Gln Met Pro Tyr
Gln Met Tyr Pro
Gln Asn Asn Tyr
Gln Asn Tyr Asn
Gln Pro Met Tyr
Gln Pro Tyr Met
Gln Tyr Met Pro
Gln Tyr Asn Asn
Gln Tyr Pro Met
Arg Cys Glu Met
Arg Cys Met Glu
Arg Glu Cys Met
Arg Glu Met Cys
Arg Met Cys Glu
Arg Met Glu Cys
Ser Asp Met Trp
Ser Asp Trp Met
Ser Met Asp Trp
Ser Met Trp Asp
Ser Trp Asp Met
Ser Trp Met Asp
Thr Cys Glu Trp
Thr Cys Trp Glu
Thr Glu Cys Trp
Thr Glu Trp Cys
Thr Met Thr Trp
Thr Met Trp Thr
Thr Thr Met Trp
Thr Thr Trp Met
Thr Trp Cys Glu
Thr Trp Glu Cys
Thr Trp Met Thr
Thr Trp Thr Met
Val Cys Met Trp
Val Cys Trp Met
Val Met Cys Trp
Val Met Trp Cys
Val Trp Cys Met
Val Trp Met Cys
Trp Ala Asp Phe
Trp Ala Phe Asp
Trp Ala Met Met
Trp Cys Asp Asp
Trp Cys Glu Thr
Trp Cys Met Val
Trp Cys Thr Glu
Trp Cys Val Met
Trp Asp Ala Phe
Trp Asp Cys Asp
Trp Asp Asp Cys
Trp Asp Phe Ala
Trp Asp Met Ser
Trp Asp Ser Met
Trp Glu Cys Thr
Trp Glu Phe Gly
Trp Glu Gly Phe
Trp Glu Thr Cys
Trp Phe Ala Asp
Trp Phe Asp Ala
Trp Phe Glu Gly
Trp Phe Gly Glu
Trp Gly Glu Phe
Trp Gly Phe Glu
Trp Met Ala Met
Trp Met Cys Val
Trp Met Asp Ser
Trp Met Met Ala
Trp Met Ser Asp
Trp Met Thr Thr
Trp Met Val Cys
Trp Ser Asp Met
Trp Ser Met Asp
Trp Thr Cys Glu
Trp Thr Glu Cys
Trp Thr Met Thr
Trp Thr Thr Met
Trp Val Cys Met
Trp Val Met Cys
Tyr Met Pro Gln
Tyr Met Gln Pro
Tyr Asn Asn Gln
Tyr Asn Gln Asn
Tyr Pro Met Gln
Tyr Pro Gln Met
Tyr Gln Met Pro
Tyr Gln Asn Asn
Tyr Gln Pro Met
KT 5720
4-Demethylsimmondsin 2'-(E)-ferulate
3-Demethylsimmondsin 2'-(Z)-ferulate
FMOC-4-METHOXY-4-(GAMMA-CARBOXYPROPYLOXY)-BENZHYDRYLAMINE
Methanesulfonamide,N-[5-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl
1H-1,4-Benzodiazepine-1-aceticacid,5-cyclohexyl-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-2-oxo-(9CI)
tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate
5-[[3,4,6-Tri-O-acetyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]pentanoic acid phenylmethyl ester
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-bis(trifluoromethyl)phenyl]-1H-pyrrole-2,5-dione
3,3-[5-[3-(3-Pyridinyl)phenyl][1,1:3,1-terphenyl]-3,3-diyl]bispyridine
N-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-D]pyrimidin-5-YL]phenyl}-N-[2-fluoro-5-(trifluoromethyl)phenyl]urea
N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-phenylbenzamide
4-(Diethylsulfamoyl)benzoic acid [2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl] ester
N-[3,5-dimethyl-1-[(4-methylphenyl)methyl]-4-pyrazolyl]-2-[[4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolin-2-yl]thio]acetamide
N-naphthalen-2-yl-2-[[6-[[2-(naphthalen-2-ylamino)-2-oxoethyl]sulfanylmethyl]pyridin-2-yl]methylsulfanyl]acetamide
(2R,4R)-N-(1H-benzimidazol-2-ylmethyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-carboxamide
6-O-(2-amino-2-deoxy-alpha-D-glucosyl)-1D-myo-inositol 1-(6-mercaptohexyl)phosphate
4-[(4R,5S)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4S,5S)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
4-[(4S,5S)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4S,5R)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4R,5R)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4R,5S)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4R,5R)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-phenylurea
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzenesulfonamide
alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo
alpha-D-Rhap4NFo-(1->3)-alpha-D-Rhap4NFo-(1->2)-alpha-D-Rhap4NFo
4-deoxy-4-formamido-alpha-D-rhamnopyranosyl-(1->2)-4-deoxy-4-formamido-alpha-D-rhamnopyranosyl-(1->2)-4-deoxy-4-formamido-alpha-D-rhamnopyranose
AR-C118925XX
AR-C118925XX is a selective P2Y2 receptor antagonist. AR-C118925XX inhibits ATP-induced IL-6 production and phosphorylation of p38. AR-C118925XX also inhibits Bleomycin (HY-108345)-induced dermal fibrosis in mice. AR-C118925XX also inhibits ATP-induced tumor growth[1][2].
OP-5244
OP-5244 is a potent and orally active inhibitor of CD73, with an IC50 of 0.25 nM. OP-5244 reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research[1].
(4s,10s,13s,16s)-3,12,15,18,21-pentahydroxy-16-[(4-hydroxyphenyl)methyl]-10,13-dimethyl-2,8,11,14,17-pentaazatricyclo[17.4.0.0⁴,⁸]tricosa-1(23),2,11,14,17,19,21-heptaen-9-one
(4s,5r,6s)-4-{[(1s)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid
(1r,14s,15r)-15-{[(5ar,6r,8r,9r,9as)-8-(hydroxymethyl)-9-methoxy-hexahydro-2h-pyrano[3,4-f][1,3,5]trioxepin-6-yl]oxy}-14-hydroxy-5,7-dioxa-12-azatetracyclo[10.5.2.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,17-dione
4-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid
14-deoxy-12-(cysteine-s-yl)-andrographo-lide-3-o-sulfate
{"Ingredient_id": "HBIN001409","Ingredient_name": "14-deoxy-12-(cysteine-s-yl)-andrographo-lide-3-o-sulfate","Alias": "NA","Ingredient_formula": "C23H39NO9S2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5163","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}